All Cancer articles – Page 9
-
Business
Pfizer teams up with GSK in cancer drug trial
Two companies will collaborate to develop a combination therapy for melanoma
-
News
£100 million for cancer research centres
Money will fund 15 research centres and 200 PhDs to target the hardest cancers to beat
-
-
Business
Amgen snaps up Onyx in huge biotech deal
$10.4 billion acquisition will expand firm’s oncology portfolio
-
Business
Nice rules against Afinitor
Novartis’ drug will not routinely be available on the UK health service
-
News
Chinese scientist sentenced over research theft
Researcher working at US university given time served for charges relating to disappearance of vials of promising drug candidate
-
Business
NHS to offer breast cancer prevention drugs
Five-year course of tamoxifen or raloxifene recommended for high risk women
-
NewsUS supreme court rules genes can't be patented
Breast cancer test company at centre of case can still rely on patents on non-naturally occurring DNA
-
NewsFukushima disaster has not raised cancer risks, says UN
Latest study at odds with others that predicted a slight increase in certain types of tumours
-
Business
Two new ‘personalised’ cancer drugs approved
Suitable patients for GSK’s melanoma treatments must be identified using an accompanying genetic test
-
Business
Judge reverses jury decision over $6.5m Takeda payout
Not enough evidence to link diabetes drug to bladder cancer, the company claims
-
NewsChinese scientist arrested for attempted research theft
Medical College of Wisconsin researcher arrested for allegedly stealing a patented cancer compound to take to a Chinese university
-
BusinessIndia rejects Novartis patent appeal
Supreme court uphold decision to refuse protection for Glivec
-
NewsFukushima disaster predicted to raise cancer rates slightly
World Health Organization report expects cancer risk to rise marginally, but doesn’t put a figure on the number of deaths expected
-
Business
Panel delivers final PFOA report
Probable link between perfluorooctanoic acid, used by DuPont to make fluoro-polymers, and high cholesterol
-
NewsReview of GM cancer scare paper
Preliminary results will be reported next week after review of the controversial paper
-
FeatureFast, flexible and flourishing
Paul Workman’s experiences in big pharma, academia and biotech gave him the tools to develop new drugs and spin out successful companies. Sarah Houlton profiles the 2012 Chemistry World entrepreneur of the year
-
-
Business
More testing needed for ridaforolimus
Marketing approval for anti-cancer drug ridaforolimus has been held up in the US